Beta-lactam antibiotic-containing tablet and production thereof

Abstract

This invention provides β-lactam antibiotic-containing tablets capable of being orally taken either as such owing to their being small-sized, hence still easily swallowable, or, in the case of administration to the aged encountering some difficulty in swallowing, in the form of dispersions resulting from easy self-disintegration upon being dropped into water in a glass as well as a method of producing the same. The tablets of this invention comprise, on the per-tablet basis, 60-85% by weight of a β-lactam antibiotic, 1-10% by weight of low-substituted hydroxypropylcellulose and/or crosslinked polyvinylpyrrolidone as a disintegrator, and 0.5-2% by weight of a binder. Granules to be compressed for tableting are prepared using water or an aqueous solution of ethanol or the like.

What is claimed is:  
     
         1 . A β-lactam antibiotic-containing tablet which comprises 60 to 85% by weight of a β-lactam antibiotic, 1 to 10% by weight of low-substituted hydroxypropylcellulose and/or crosslinked polyvinylpyrrolidone as a disintegrator and 0.5 to 2% by weight of a binder per tablet.  
     
     
         2 . A tablet as claimed in  claim 1 , wherein the binder is polyvinylpyrrolidone, hydroxypropylcellulose or hydroxypropylmethylcellulose.  
     
     
         3 . A tablet as claimed in  claim 1  or  2  which further comprises 0.5 to 15% by weight of a synthetic sweetener and/or a granulated synthetic sweetener.  
     
     
         4 . A tablet as claimed in  claim 3 , wherein the synthetic sweetener or the granulated synthetic sweetener has an mean particle size of not less than 150 μm.  
     
     
         5 . A tablet as claimed in  claim 4 , wherein the synthetic sweetener or the granulated synthetic sweetener is not less than 150 μm in particle size.  
     
     
         6 . A tablet as claimed in  claim 3 , wherein the granulated synthetic sweetener comprises a synthetic sweetener, and light anhydrous silicic acid and/or hydrated silicon dioxide.  
     
     
         7 . A tablet as claimed in any of  claims 1  to  6 , wherein the β-lactam antibiotic is cefixime or cefdinir.  
     
     
         8 . A tablet as claimed in  claim 7  which contains 400 mg potency of cefixime, the tablet weight being not greater than 650 mg.  
     
     
         9 . A tablet as claimed in  claim 7  which contains 300 mg potency of cefdinir, the tablet weight being not greater than 450 mg.  
     
     
         10 . A method of producing β-lactam antibiotic-containing tablets which comprises admixing a synthetic sweetener and/or a granulated synthetic sweetener, optionally together with one or more other additives, with a granulation product prepared from the β-lactam antibiotic, disintegrator and binder specified in  claim 1 , optionally together with one or more excipients, by using ethanol, isopropyl alcohol or an aqueous solution of ethanol or isopropyl alcohol, and then tableting the resulting mixture.